Tuesday, January 03, 2012 10:08 PM
Less Money for Med-tech Start-ups
Nationwide survey finds that 58 percent of early-stage investors predict that there will be fewer investments in biopharmaceutical and medical device businesses.
A new nationwide survey from the National Venture Capital Association found that 58 percent of the early-stage investors predict that there will be fewer investments in biopharmaceutical and medical device businesses. Mark Heesen, the association's president, said that "externalities" are keeping optimism at bay. Those issues include economic uncertainty in the United States and abroad, along with public policy issues. For device companies, the key issue has been uncertainty more...
|
Please log in or become a member...
To continue reading this content you must either log in become a member. If you are already a member, please log in using the form below. If you are not already a member, we invite you to join our online community. Membership is free of charge to personnel working in industry, academia, and government.
To join please click on the "Become a Member" link at the top of the page (joining takes around 1 minute and you only need to register once).
Membership benefits include free access to:
-
Industry news, feature articles, podcasts, videos and blogs
-
Weekly eNewsletter subscription
-
Resource Center including downloadable brochures, white papers, reports & media files
-
Industry events calendar
Thank you!
|
Be the first to leave a comment.
Post your comments about this article or questions for the author here